Click on the panels below to find out more about our latest hosted content
A survey of 710 people with rosacea and 554 doctors has revealed valuable insights on the invisible impact of a visible disease for the patients and the community. It is time to fight back against stereotypes and talk openly about rosacea burden.
Learn more about Galapagos, and our sponsored activities during ECCO.
Intended for Healthcare professionals. This programme is not affiliated with ECCO.
Code: GL-IBD-NA-202105-00016 Date of Preparation: May 2021
Click here for prescribing information and adverse events reporting. This content is promotional and has been developed, organised and funded by Lilly.Intended for UK healthcare professionals only.
PP-BA-GB-1049 September 2021